Sanofi (SNYNF) News Today

$95.54
+1.54 (+1.64%)
(As of 04/25/2024 ET)
SourceHeadline
markets.businessinsider.com logoSanofi Q1 Profit Drops, Sales Rise; Confirms FY24 Outlook
markets.businessinsider.com - April 25 at 2:58 AM
wsj.com logoSanofi Pharma Ltd.
wsj.com - April 23 at 3:32 PM
msn.com logoSanofi succeeds in late-stage trial for blood disorder candidate
msn.com - April 23 at 10:31 AM
markets.businessinsider.com logoMaintaining Buy Rating on Sanofi: A Resilient Financial Outlook Despite Currency Headwinds
markets.businessinsider.com - April 18 at 7:41 AM
msn.com logoNo link between weight loss drugs and suicidal thoughts, EU regulator concludes
msn.com - April 12 at 8:16 AM
msn.com logoU.S. CDC warns bacteria causing meningitis are on the rise
msn.com - March 30 at 2:21 PM
seekingalpha.com logoSanofi: My Top Pick In Big Pharma
seekingalpha.com - March 25 at 2:49 AM
marketbeat.com logo6 reasons to buy Teva Pharmaceuticals stock sooner than later (SNYNF)
marketbeat.com - February 26 at 6:20 AM
msn.com logoSanofi (SNYNF) Price Target Increased by 6.32% to 117.27
msn.com - February 24 at 7:18 AM
markets.businessinsider.com logoBuy Rating Affirmed for Sanofi on Strong Sales and Promising Financial Outlook
markets.businessinsider.com - February 5 at 10:22 AM
finance.yahoo.com logoPress Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
finance.yahoo.com - February 2 at 12:39 AM
markets.businessinsider.com logoSanofi Posts Q4 Loss, Sees Stable FY24 Business EPS; Names Nestle's Francois-Xavier Roger CFO
markets.businessinsider.com - February 1 at 4:37 AM
marketbeat.com logo20 best healthcare dividend stocks to invest in (SNYNF)
marketbeat.com - January 19 at 12:02 PM
finance.yahoo.com logoSanofi: Information concerning the total number of voting rights and shares - November 2023
finance.yahoo.com - December 18 at 6:26 PM
marketbeat.com logoTeva Pharma is the way to play the re-rise of generic drugs (SNYNF)
marketbeat.com - November 28 at 6:25 AM
marketbeat.com logoInformatica soars on its AI-powered data management cloud growth (SNYNF)
marketbeat.com - November 13 at 2:15 PM
msn.com logoSanofi said to be under scrutiny over possible market manipulation
msn.com - November 7 at 1:06 PM
marketbeat.com logoPfizer and Sanofi shares fall, which one to scoop up? (SNYNF)
marketbeat.com - November 7 at 6:17 AM
finance.yahoo.com logoSanofi honors 10 advocacy organizations promoting health equity solutions in underserved U.S. communities
finance.yahoo.com - November 2 at 2:49 PM
msn.com logoAnalyzing The Acquisition Potential Of ImmunoGen
msn.com - November 1 at 8:44 AM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Sanofi (SNYNF)
markets.businessinsider.com - October 30 at 11:24 PM
morningstar.com logoSanofi SA SAN Stock Quote
morningstar.com - October 28 at 1:36 PM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: Resmed (RMD), Sanofi (OtherSNYNF) and Viking Therapeutics (VKTX)
markets.businessinsider.com - October 27 at 8:30 PM
finanznachrichten.de logosanofi-aventis Korea: Sanofi Bridging the Gap between the Homeless and Society via Futsal
finanznachrichten.de - October 24 at 12:44 AM
finance.yahoo.com logoPress Release: Sanofi delivers first medicines from Global Health Unit’s Impact brand portfolio
finance.yahoo.com - October 19 at 7:58 AM
markets.businessinsider.com logoSanofi’s Amlitelimab: Risinger’s Positive Outlook Based on Efficacy Data and Future Trials
markets.businessinsider.com - October 18 at 7:03 AM
finance.yahoo.com logoSanofi Bridging the Gap between the Homeless and Society via Futsal
finance.yahoo.com - October 17 at 9:39 AM
finance.yahoo.com logoPress Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli
finance.yahoo.com - October 3 at 1:53 AM
marketbeat.com logoHere are 3 AI Drug Discovery Stocks to Put on Your Watchlist (SNYNF)
marketbeat.com - August 1 at 7:00 AM
nasdaq.com logoSanofi Q2 Profit Rises, Sales Up 3.3% At CER; Raises 2023 Business EPS Guidance
nasdaq.com - July 28 at 8:20 AM
markets.businessinsider.com logoBank of America Securities Sticks to Their Buy Rating for Sanofi (SNYNF)
markets.businessinsider.com - July 28 at 8:20 AM
marketbeat.com logoExscientia is the Sniper of the AI Drug Discovery Industry (SNYNF)
marketbeat.com - July 27 at 10:36 AM
markets.businessinsider.com logoSanofi (SNYNF) Gets a Sell from Deutsche Bank
markets.businessinsider.com - July 21 at 10:02 AM
markets.businessinsider.com logoBerenberg Bank Sticks to Its Hold Rating for Sanofi (SNYNF)
markets.businessinsider.com - July 6 at 9:27 AM
markets.businessinsider.com logoDeutsche Bank Remains a Sell on Sanofi (SNYNF)
markets.businessinsider.com - July 3 at 6:16 PM
markets.businessinsider.com logoSanofi Prevails In Zantac Arbitration In International Chamber Of Commerce Dispute - Quick Facts
markets.businessinsider.com - June 20 at 2:32 AM
marketbeat.com logoDarioHealth is an AI-Powered Digital Therapeutics Play (SNYNF)
marketbeat.com - June 13 at 8:35 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Sanofi (OtherSNYNF) and Bristol Myers (BMY)
markets.businessinsider.com - June 8 at 1:06 PM
uk.finance.yahoo.com logoSNYNF - Sanofi
uk.finance.yahoo.com - May 31 at 10:27 PM
markets.businessinsider.com logoJ.P. Morgan Sticks to Their Buy Rating for Sanofi (SNYNF)
markets.businessinsider.com - May 31 at 7:24 AM
markets.businessinsider.com logoSanofi: Nirsevimab Delivers 83% Reduction In RSV Infant Hospitalizations In Phase 3b Trial
markets.businessinsider.com - May 12 at 8:14 AM
thestreet.com logoMerck to Sell Merial Stake to Sanofi for $4B
thestreet.com - May 11 at 11:07 AM
thestreet.com logoAmgen Victorious Over Regeneron, Sanofi in Cholesterol Drug Patent Lawsuit
thestreet.com - May 10 at 7:45 PM
markets.businessinsider.com logoJ.P. Morgan Sticks to Its Buy Rating for Sanofi (SNYNF)
markets.businessinsider.com - May 2 at 9:09 AM
markets.businessinsider.com logoSanofi (SNYNF) was downgraded to a Sell Rating at Deutsche Bank
markets.businessinsider.com - May 2 at 9:09 AM
markets.businessinsider.com logoDeutsche Bank Reaffirms Their Hold Rating on Sanofi (SNYNF)
markets.businessinsider.com - April 28 at 12:05 PM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF) and Sanofi (OtherSNYNF)
markets.businessinsider.com - April 27 at 10:59 AM
markets.businessinsider.com logoJ.P. Morgan Keeps Their Buy Rating on Sanofi (SNYNF)
markets.businessinsider.com - April 21 at 7:08 AM
seekingalpha.com logoRegeneron draws more bullish views from analysts after Dupixent COPD data
seekingalpha.com - March 24 at 12:17 PM
markets.businessinsider.com logoBerenberg Bank Sticks to Their Hold Rating for Sanofi (SNYNF)
markets.businessinsider.com - March 24 at 7:14 AM
Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNYNF and its competitors with MarketBeat's FREE daily newsletter.

What is Medicare Supplement Insurance? (Ad)

Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.

Learn More Here

SNYNF Media Mentions By Week

SNYNF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNYNF
News Sentiment

0.38

0.34

Average
Medical
News Sentiment

SNYNF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNYNF Articles
This Week

3

0

SNYNF Articles
Average Week

Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNYNF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:SNYNF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners